Predict your next investment

HEALTHCARE | Drug Development

See what CB Insights has to offer

Stage

Acquired | Acquired

Total Raised

$46M

About Elitra Pharmaceuticals

Antimicrobial functional genomics company focused on the identification, development and commercialization of antimicrobial compounds that target essential gene products of pathogenic organisms. Elitra has a research collaboration in place with Merck & Co. Assets acquired by Merck in 2004.

Elitra Pharmaceuticals Headquarter Location

3510 Dunhill Street

San Diego, California, 92121,

United States

858-410-3030

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Expert Collections containing Elitra Pharmaceuticals

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Elitra Pharmaceuticals is included in 1 Expert Collection, including Omics.

O

Omics

1,213 items

Companies involved in the capture, sequencing, and/or analysis of genomic, transcriptomic, proteomic, and/or metabolomic data

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.